Rosuvastatin undergoes limited metabolism, principally by the cytochrome P450 isoenzyme CYP2C9, and may not have the same interactions with enzyme inhibitors as simvastatin. However, increased rosuvastatin plasma concentrations have been reported with ciclosporins and, to a lesser extent, with gemfibrozil, and such combinations should be avoided.